Cargando…

Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting

BACKGROUND: Photoimmunotherapy involves targeted delivery of photosensitizers via an antibody conjugate (i.e., photoimmunoconjugate, PIC) followed by light activation for selective tumor killing. The trade-off between PIC selectivity and PIC uptake is a major drawback limiting the efficacy of photoi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Barry J., Pigula, Michael, Baglo, Yan, Najafali, Daniel, Hasan, Tayyaba, Huang, Huang-Chiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939330/ https://www.ncbi.nlm.nih.gov/pubmed/31898555 http://dx.doi.org/10.1186/s12951-019-0560-5

Ejemplares similares

Use of photoimmunoconjugates to characterize ABCB1 in cancer cells
por: Liang, Barry J., et al.
Publicado: (2021)

A fluorescent photoimmunoconjugate for imaging of cholesteatoma
por: Early, Samuel, et al.
Publicado: (2022)

Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy
por: Sorrin, Aaron J., et al.
Publicado: (2023)

Fighting Staphylococcus aureus infections with light and photoimmunoconjugates
por: Bispo, Mafalda, et al.
Publicado: (2020)

Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer
por: Takada, Ryoji, et al.
Publicado: (2023)

Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan
por: Ko, Andrew H
Publicado: (2016)

Nanoliposomal irinotecan in combination with leucovorin and 5-fluorouracil in advanced biliary tract cancers
por: Allo, Gabriel, et al.
Publicado: (2022)

Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
por: Chang, T. C., et al.
Publicado: (2015)

Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
por: Glassman, Danielle C., et al.
Publicado: (2018)

Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer.
por: Duska, L. R., et al.
Publicado: (1997)

Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin
por: Kawakami, Takeshi, et al.
Publicado: (2023)

Breaking the trade-off between selectivity and adsorption capacity for gas separation
por: Kumar, Naveen, et al.
Publicado: (2021)

A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic Cancer
por: Ikoma, Tatsuki, et al.
Publicado: (2023)

The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma
por: Procaccio, Letizia, et al.
Publicado: (2023)

Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer
por: Hamblin, M R, et al.
Publicado: (2000)

Development and characterization of lactoferrin nanoliposome: cellular uptake and stability
por: Guan, Rongfa, et al.
Publicado: (2012)

First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2022)

Breaking of the Trade-Off Principle between Computational Universality and Efficiency by Asynchronous Updating
por: Gunji, Yukio-Pegio, et al.
Publicado: (2020)

Dual-Functionalized Nanoliposomes Achieve a Synergistic Chemo-Phototherapeutic Effect
por: Lazaro-Carrillo, Ana, et al.
Publicado: (2022)

Synergistic Effects of Simvastatin and Irinotecan against Colon Cancer Cells with or without Irinotecan Resistance
por: Jang, Hyun Joo, et al.
Publicado: (2016)

Thin-film composite membrane breaking the trade-off between conductivity and selectivity for a flow battery
por: Dai, Qing, et al.
Publicado: (2020)

Parasites and competitors suppress bacterial pathogen synergistically due to evolutionary trade‐offs
por: Wang, Xiaofang, et al.
Publicado: (2016)

PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM‐398) or irinotecan with leucovorin/5‐fluorouracil as second‐line therapy in metastatic colorectal cancer
por: Chibaudel, Benoist, et al.
Publicado: (2016)

Breaking the trade-off between fast control and long lifetime of a superconducting qubit
por: Kono, S., et al.
Publicado: (2020)

Novel concepts in atrial fibrillation ablation—breaking the trade‐off between efficacy and safety
por: Althoff, Till F., et al.
Publicado: (2021)

A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7
por: Fox, Christopher B, et al.
Publicado: (2014)

Long-Term Survival of a Patient With Peritoneal Carcinomatosis From Pancreatic Cancer Maintained by Nanoliposomal Irinotecan as Third-Line Chemotherapy
por: Nagata, Keiji, et al.
Publicado: (2022)

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2022)

ATLAS Off-Grid sites (Tier-3) monitoring
por: Petrosyan, A S
Publicado: (2012)

Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies
por: Mangalea, Mihnea R., et al.
Publicado: (2020)

Breaking the trade-off between thermal and electrical conductivities in the thermoelectric material of an artificially tilted multilayer
por: Sakai, Akihiro, et al.
Publicado: (2014)

Breaking through the strength-ductility trade-off dilemma in an Al-Si-based casting alloy
por: Dang, B., et al.
Publicado: (2016)

Black Silicon: Breaking through the Everlasting Cost vs. Effectivity Trade-Off for SERS Substrates
por: Golubewa, Lena, et al.
Publicado: (2023)

Longitudinal tumor hypoxia imaging with [(18)F]FAZA-PET provides early prediction of nanoliposomal irinotecan (nal-IRI) treatment activity
por: Zheng, Jinzi, et al.
Publicado: (2015)

FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study
por: Kobayashi, Satoshi, et al.
Publicado: (2023)

Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experience and review of literature
por: Möhring, Christian, et al.
Publicado: (2023)

Life History Trade-Offs in Tumors
por: Boddy, Amy M., et al.
Publicado: (2018)

Publisher Correction: Thin-film composite membrane breaking the trade-off between conductivity and selectivity for a flow battery
por: Dai, Qing, et al.
Publicado: (2020)

Trade-offs in Thailand.
por: Taylor, D
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_noejdpfpes0r3s44k8hob03n4g